Reply to: Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population

Laurens A. van Kleef; Milan J. Sonneveld; Robert J. de Knegt

doi:10.1016/j.cgh.2022.02.011

Reply to: Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population

Laurens A. van Kleef
, Milan J. Sonneveld
, Robert J. de Knegt

Gastroenterology & Hepatology

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

1 Citation (Scopus)

Abstract

Dear Editor:
With nonalcoholic fatty liver disease prevalence rising rapidly, the population at risk for advanced chronic liver disease and its complications has expanded significantly. Hence, there is an urgent need for accurate noninvasive tools to identify individuals who could benefit from a referral to a hepatologist. We therefore read with great interest the article "Low accuracy of FIB-4 and nonalcoholic fatty liver disease fibrosis scores (NFS) for screening for liver fibrosis in the population" recently published in Clinical Gastroenterology and Hepatology. [...]

Original language	English
Pages (from-to)	238-239
Number of pages	2
Journal	Clinical Gastroenterology and Hepatology
Volume	21
Issue number	1
Early online date	10 Feb 2022
DOIs	https://doi.org/10.1016/j.cgh.2022.02.011
Publication status	Published - Jan 2023

Bibliographical note

Funding Information:
Funding Financial support was provided by the Foundation for Liver and Gastrointestinal Research, Rotterdam, the Netherlands. The funding source did not influence study design, nor the writing of the report and decision to submit for publication.

Access to Document

10.1016/j.cgh.2022.02.011

Cite this

@article{8c07e85779ee4f6488705482ee3d5bd0,

title = "Reply to: Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population",

abstract = "Dear Editor: With nonalcoholic fatty liver disease prevalence rising rapidly, the population at risk for advanced chronic liver disease and its complications has expanded significantly. Hence, there is an urgent need for accurate noninvasive tools to identify individuals who could benefit from a referral to a hepatologist. We therefore read with great interest the article {"}Low accuracy of FIB-4 and nonalcoholic fatty liver disease fibrosis scores (NFS) for screening for liver fibrosis in the population{"} recently published in Clinical Gastroenterology and Hepatology. [...] ",

author = "\{van Kleef\}, \{Laurens A.\} and Sonneveld, \{Milan J.\} and \{de Knegt\}, \{Robert J.\}",

note = "Funding Information: Funding Financial support was provided by the Foundation for Liver and Gastrointestinal Research, Rotterdam, the Netherlands. The funding source did not influence study design, nor the writing of the report and decision to submit for publication. ",

year = "2023",

month = jan,

doi = "10.1016/j.cgh.2022.02.011",

language = "English",

volume = "21",

pages = "238--239",

journal = "Clinical Gastroenterology and Hepatology",

issn = "1542-3565",

number = "1",

}

TY - JOUR

T1 - Reply to: Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population

AU - van Kleef, Laurens A.

AU - Sonneveld, Milan J.

AU - de Knegt, Robert J.

N1 - Funding Information: Funding Financial support was provided by the Foundation for Liver and Gastrointestinal Research, Rotterdam, the Netherlands. The funding source did not influence study design, nor the writing of the report and decision to submit for publication.

PY - 2023/1

Y1 - 2023/1

N2 - Dear Editor: With nonalcoholic fatty liver disease prevalence rising rapidly, the population at risk for advanced chronic liver disease and its complications has expanded significantly. Hence, there is an urgent need for accurate noninvasive tools to identify individuals who could benefit from a referral to a hepatologist. We therefore read with great interest the article "Low accuracy of FIB-4 and nonalcoholic fatty liver disease fibrosis scores (NFS) for screening for liver fibrosis in the population" recently published in Clinical Gastroenterology and Hepatology. [...]

AB - Dear Editor: With nonalcoholic fatty liver disease prevalence rising rapidly, the population at risk for advanced chronic liver disease and its complications has expanded significantly. Hence, there is an urgent need for accurate noninvasive tools to identify individuals who could benefit from a referral to a hepatologist. We therefore read with great interest the article "Low accuracy of FIB-4 and nonalcoholic fatty liver disease fibrosis scores (NFS) for screening for liver fibrosis in the population" recently published in Clinical Gastroenterology and Hepatology. [...]

UR - https://www.scopus.com/pages/publications/85143658917

U2 - 10.1016/j.cgh.2022.02.011

DO - 10.1016/j.cgh.2022.02.011

M3 - Comment/Letter to the editor

C2 - 35151862

AN - SCOPUS:85143658917

SN - 1542-3565

VL - 21

SP - 238

EP - 239

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

IS - 1

ER -

Reply to: Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this